Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (211-220 of 6,083) with videos related to

Pageof 609
Sort By:
The Prostate|August 29, 2021
MEX3D is an oncogenic driver in prostate cancerLongjiang Shao, Jianghua Wang, Omer Karatas, et al.
The Prostate|January 1, 1983
Indomethacin decreases both prolactin binding and membrane fluidity of ventral and dorso-lateral lobes of rat prostate glandJ R Dave, R J Witorsch
The Prostate|January 1, 1983
Studies on the structural basis of the heterogeneity of human prostatic and seminal acid phosphatasesE M Taga, D L Moore, R L Van Etten
The Prostate|January 1, 1983
Evidence against a zinc binding peptide in pilocarpine-stimulated canine prostatic secretionsR F Parrish, E P Perinetti, W R Fair
The Prostate|August 30, 2025
Mechanical-Inflammatory Protection: Explaining Favorable Oncological Outcomes in Large ProstatesYu-Hsiang Lin, Jau-Yuan Chen, Chun-Te Wu
The Prostate|September 2, 2025
Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer TreatmentKazuma Yukihiro, Yohei Sekino, Go Kobayashi, et al.
The Prostate|May 28, 2015
Transcriptional regulation of BNIP3 by Sp3 in prostate cancerYing Huang, Pengfei Shen, Xueqin Chen, et al.
The Prostate|May 6, 2020
Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort studyPer-Olof Lundgren, Anders Kjellman, Ulf Norming, et al.
The Prostate|January 1, 1985
Long-term follow-up of patients with advanced prostatic carcinoma treated with either buserelin (HOE 766) or orchiectomy: classification of variables associated with disease outcomeM Koutsilieris, G Tolis
The Prostate|November 20, 1997
Functional property, norepinephrine content and morphometric findings in human hyperplastic prostateM Ishigooka, T Hashimoto, Y Suzuki, et al.
Pageof 609

Showing results (211-220 of 6,083) with videos related to

Sort By:
Pageof 609
The Prostate|August 29, 2021
MEX3D is an oncogenic driver in prostate cancerLongjiang Shao, Jianghua Wang, Omer Karatas, et al.
The Prostate|January 1, 1983
Indomethacin decreases both prolactin binding and membrane fluidity of ventral and dorso-lateral lobes of rat prostate glandJ R Dave, R J Witorsch
The Prostate|January 1, 1983
Studies on the structural basis of the heterogeneity of human prostatic and seminal acid phosphatasesE M Taga, D L Moore, R L Van Etten
The Prostate|January 1, 1983
Evidence against a zinc binding peptide in pilocarpine-stimulated canine prostatic secretionsR F Parrish, E P Perinetti, W R Fair
The Prostate|August 30, 2025
Mechanical-Inflammatory Protection: Explaining Favorable Oncological Outcomes in Large ProstatesYu-Hsiang Lin, Jau-Yuan Chen, Chun-Te Wu
The Prostate|September 2, 2025
Comprehensive Analysis of Fraction of Genome Altered in Prostate Cancer TreatmentKazuma Yukihiro, Yohei Sekino, Go Kobayashi, et al.
The Prostate|May 28, 2015
Transcriptional regulation of BNIP3 by Sp3 in prostate cancerYing Huang, Pengfei Shen, Xueqin Chen, et al.
The Prostate|May 6, 2020
Association between dihydrotestosterone and long-term risk for prostate cancer mortality: A prospective cohort studyPer-Olof Lundgren, Anders Kjellman, Ulf Norming, et al.
The Prostate|January 1, 1985
Long-term follow-up of patients with advanced prostatic carcinoma treated with either buserelin (HOE 766) or orchiectomy: classification of variables associated with disease outcomeM Koutsilieris, G Tolis
The Prostate|November 20, 1997
Functional property, norepinephrine content and morphometric findings in human hyperplastic prostateM Ishigooka, T Hashimoto, Y Suzuki, et al.
Pageof 609